4 Midcap High Quarterly Margin and High ROE Stocks to Watch for Future Multibagger Potential: Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama

High quarterly margin and high ROE stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama meet that test, with market caps from Rs 32,663 crore to Rs 62,923 crore and Nippon Life India AMC offering the highest return on equity at 32.83%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a latest quarter operating margin of at least 20 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a latest quarter operating margin of at least 20 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening high quarterly margin and high ROE stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are High Quarterly Margin and High ROE Stocks and Why Do They Attract Multibagger Interest?

High quarterly margin and high ROE stocks are shares of mid sized companies that kept at least twenty paise of operating profit from every rupee of sales in the latest quarter and earn a return on equity of twenty per cent or more, a mix that marks a strong and efficient business. The four here cover asset management, pharmaceuticals, copper mining and wealth management.

A high margin in the latest quarter shows current pricing power, and a high return on equity shows that shareholder money is used well, so the two together point to a business with a real edge. Within high quarterly margin and high ROE stocks, the four companies show rising profit. In high quarterly margin and high ROE stocks, each of the four also posted growth in the latest quarter. For high quarterly margin and high ROE stocks, both FY26 and the latest quarter showed growth. Whichever way you read high quarterly margin and high ROE stocks, the common thread is rising profit backed by complete financial data. A sensible way to study high quarterly margin and high ROE stocks is to look at profit growth, returns and valuation side by side. Below, each of high quarterly margin and high ROE stocks gets its own breakdown of growth, returns and valuation. Treat high quarterly margin and high ROE stocks as a research list, since share prices and rankings change with every earnings season.

High Quarterly Margin and High ROE Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 30 October 2026. Nuvama has the lowest PE of the group at 30.19, while Nippon Life India AMC posts the highest return on equity at 32.83%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Nippon Life India Asset Management	905	62,923	38.43	17.70	32.83%	13.50	795.80 to 1,269.50
Ajanta Pharma	3,508.80	44,167	38.92	36.35	23.33%	9.75	2,380.20 to 3,796.00
Hindustan Copper	400.85	39,822	35.05	12.27	27.48%	11.91	308.50 to 760.05
Nuvama Wealth Management	1,736	32,663	30.19	33.31	25.26%	7.96	1,096.90 to 2,066.00

Nippon Life India AMC: Return on Equity of 32.83%

Nippon Life India Asset Management is one of the largest mutual fund houses in India and also runs ETFs and portfolio management services. It reported FY26 revenue of Rs 2,933.07 crore, up 16.36% year on year, and net profit of Rs 1,528.13 crore, up 18.85%. Net profit has compounded at 19.74% a year since FY22, while revenue has grown 17.56% a year. Operating margin was 68.84% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.

In the June 2026 quarter, revenue rose 24.51% to Rs 937.08 crore and net profit grew 27.15% to Rs 503.09 crore. The share price has gained 131.06% over five years and 20.07% over the past year. Domestic institutions raised their holding from 13.45% in June 2025 to 15.49% in June 2026. The stock trades at a PE of 38.43 against an industry PE of 17.70, with a return on equity of 32.83%. The dividend yield is 2.18%.

Ajanta Pharma: Return on Equity of 23.33%

Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

The stock trades at a PE of 38.92 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.

Hindustan Copper: 25.25% Profit CAGR Since FY22

Hindustan Copper is a government-owned company that mines copper ore and produces refined copper in India. It reported FY26 revenue of Rs 3,149.67 crore, up 46.62% year on year, and net profit of Rs 920.66 crore, up 96.97%. Net profit has compounded at 25.25% a year since FY22, while revenue has grown 13.89% a year. Operating margin was 46.74% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.

In the June 2026 quarter, revenue rose 81.07% to Rs 953.60 crore and net profit grew 162.59% to Rs 352.61 crore. The share price has gained 205.23% over five years and 33.08% over the past year. Foreign investors raised their holding from 3.71% in June 2025 to 5.96% in June 2026. The stock trades at a PE of 35.05 against an industry PE of 12.27, with a return on equity of 27.48%.

Nuvama: Return on Equity of 25.26%

Nuvama Wealth Management offers wealth management, asset services and capital markets services to affluent clients and institutions. It reported FY26 revenue of Rs 4,649.65 crore, up 11.52% year on year, and net profit of Rs 1,040.26 crore, up 5.60%. Revenue has compounded at 27.07% a year since FY22. Operating margin was 53.05% in FY26.

The stock trades at a PE of 30.19 against an industry PE of 33.31, below the sector average, with a return on equity of 25.26%. The dividend yield is 1.55%. In the June 2026 quarter, revenue rose 22.88% to Rs 1,381.96 crore and net profit grew 15.83% to Rs 305.64 crore. The share price is up 19.71% over the past year. Domestic institutions raised their holding from 6.37% in June 2025 to 8.49% in June 2026.

High Quarterly Margin and High ROE Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these high quarterly margin and high ROE stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
Nippon Life India AMC	2,933.07	1,528.13	16.36%	17.56%	19.74%	88.41%
Ajanta Pharma	5,624.93	1,056	18.60%	12.94%	10.33%	30.41%
Hindustan Copper	3,149.67	920.66	46.62%	13.89%	25.25%	56.02%
Nuvama	4,649.65	1,040.26	11.52%	27.07%	4.96%	53.22%

Check the Univest Screener for live data on these high quarterly margin and high ROE stocks

Institutional Holding in Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama

Institutional holding shows who is backing these high quarterly margin and high ROE stocks alongside the promoter. The table uses the latest reported quarter for each. Ajanta Pharma has the deepest institutional backing, with FII and DII together holding 29.57% as of September 2026. Domestic institutions increased their holding over the past year in Nippon Life India AMC (from 13.45% to 15.49%), Ajanta Pharma (from 17.90% to 21.94%) and Nuvama (from 6.37% to 8.49%).

Stock	Promoter	FII	DII	Public	Quarter
Nippon Life India AMC	71.80%	7.04%	15.49%	5.67%	June 2026
Ajanta Pharma	63.47%	7.63%	21.94%	6.96%	September 2026
Hindustan Copper	66.14%	5.96%	4.84%	23.06%	June 2026
Nuvama	53.98%	19.00%	8.49%	18.53%	June 2026

Risks to Weigh in High Quarterly Margin and High ROE Stocks

Being careful with high quarterly margin and high ROE stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Hindustan Copper trades at a PE of 35.05 against an industry PE of 12.27, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between High Quarterly Margin and High ROE Stocks

Picking from high quarterly margin and high ROE stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.27 to 36.35) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama live prices.

Conclusion

Among high quarterly margin and high ROE stocks, Nippon Life India AMC stands out for the highest return on equity at 32.83%, Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06, Hindustan Copper for the fastest profit growth, 25.25% a year since FY22 and Nuvama for the lowest PE of the group at 30.19. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high quarterly margin and high ROE stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on High Quarterly Margin and High ROE Stocks to Watch

Which are the best high quarterly margin and high ROE stocks to watch for multibagger potential?

Ans. Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama are the 4 names this list highlights, with market caps of Rs 62,923 crore, Rs 44,167 crore, Rs 39,822 crore and Rs 32,663 crore respectively. Nippon Life India AMC is notable for the highest return on equity at 32.83%. Ajanta Pharma stands out for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Hindustan Copper offers the fastest profit growth, 25.25% a year since FY22. Nuvama brings the lowest PE of the group at 30.19. These are watchlist names for high quarterly margin and high ROE stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Nippon Life India AMC a good stock for long-term investors?

Ans. Nippon Life India AMC has a return on equity of 32.83%, a PE of 38.43 against an industry PE of 17.70 and a market cap of Rs 62,923 crore. Net profit has compounded at 19.74% a year since FY22, and FY26 revenue rose 16.36% while June 2026 quarter net profit grew 27.15%. Long-term returns in high quarterly margin and high ROE stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Hindustan Copper become a multibagger from here?

Ans. Hindustan Copper has already gained 205.23% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high quarterly margin and high ROE stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 25.25% a year since FY22, and FY26 revenue rose 46.62%. At a PE of 35.05 against an industry PE of 12.27, valuation should be checked against that growth before investing.

What is the market cap of Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama?

Ans. As of 30 October 2026, Nippon Life India AMC has a market cap of Rs 62,923 crore, Ajanta Pharma has a market cap of Rs 44,167 crore, Hindustan Copper has a market cap of Rs 39,822 crore and Nuvama has a market cap of Rs 32,663 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high quarterly margin and high ROE stocks.

What are the risks of investing in high quarterly margin and high ROE stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Hindustan Copper trades at a PE of 35.05 against an industry PE of 12.27, so earnings growth needs to hold up.

Why is Hindustan Copper trading at a PE of 35.05?

Ans. Hindustan Copper’s PE of 35.05 compares with an industry PE of 12.27. The market is paying a premium for a return on equity of 27.48%, profit growth of 25.25% a year since FY22 and latest-quarter profit growth of 162.59%, which also means the stock is more sensitive if growth slows. Investors in high quarterly margin and high ROE stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Nippon Life India AMC, Ajanta Pharma, Hindustan Copper and Nuvama?

Ans. As of the latest reported quarter, FII and DII together hold 22.53% of Nippon Life India AMC (7.04% and 15.49%), 29.57% of Ajanta Pharma (7.63% and 21.94%), 10.80% of Hindustan Copper (5.96% and 4.84%) and 27.49% of Nuvama (19.00% and 8.49%). Rising institutional holding is a useful signal in high quarterly margin and high ROE stocks, though it should be read with earnings trends rather than on its own.